Aurita Bioscience specializes in advanced 3D cell culture technologies that prioritize the microenvironment and cellular interactions over traditional monolayer cultures. Their flagship technology, Liquid-Like Solids (LLS™), is a unique microgel-based medium that maintains a liquid-like consistency while providing a stable support structure for biological samples. This innovative medium allows for tunable mechanical properties and surface bio-conjugation, enabling researchers to create customized environments that closely mimic in vivo conditions. The LLS™ microgels facilitate high-resolution imaging and real-time cell tracking, making them ideal for studying complex cellular behaviors, such as migration and interaction within a 3D context.

In addition to LLS™, Aurita offers Darcy Plates™, which enable passive perfusion of culture media through the microgel bed, emulating the physiological transport dynamics found in living tissues. This system enhances nutrient and waste transport, supporting high-density cell cultures and long-term viability of samples. Aurita's technologies are designed to be compatible with existing laboratory workflows, allowing for seamless integration into research settings. Their applications span various fields, including oncology, infectious disease, and personalized medicine, providing valuable insights into cellular mechanisms and therapeutic responses.

United States

Aurita Corp is a synthetic biology startup that creates a platform for 3D bioscience intended to provide personalized medicine and diagnostics, therapeutic solutions, and cell culture tools.

Aurita Bioscience

Company Details